JY
CODX

Jeff Yass’s Co-Diagnostics CODX Stock Holding History

Jeff Yass’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.8K Buy
+31,239
New +$96.1K ﹤0.01% 12518
2026
Q1 		– Sell
-1,642
Closed -$8.3K – 13279
2025
Q4 		$8.3K Buy
1,642
+137
+9% +$1.49K ﹤0.01% 12072
2025
Q3 		$15.5K Sell
1,505
-2,664
-64% -$24.8K ﹤0.01% 12075
2025
Q2 		$35K Sell
4,169
-2,942
-41% -$27.5K ﹤0.01% 12208
2025
Q1 		$66K Sell
7,111
-1,527
-18% -$29.2K ﹤0.01% 11764
2024
Q4 		$194K Buy
8,638
+2,386
+38% +$75.4K ﹤0.01% 10757
2024
Q3 		$234K Sell
6,252
-467
-7% -$17.9K ﹤0.01% 10141
2024
Q2 		$252K Buy
6,719
+3,564
+113% +$130K ﹤0.01% 9839
2024
Q1 		$106K Sell
3,155
-435
-12% -$15.8K ﹤0.01% 11182
2023
Q4 		$143K Buy
3,590
+880
+32% +$31K ﹤0.01% 11015
2023
Q3 		$86.2K Buy
2,710
+1,498
+124% +$56.6K ﹤0.01% 11033
2023
Q2 		$40.4K Buy
1,212
+117
+11% +$4.48K ﹤0.01% 11416
2023
Q1 		$48.6K Sell
1,095
-3,176
-74% -$255K ﹤0.01% 11708
2022
Q4 		$323K Sell
4,271
-1,047
-20% -$98K ﹤0.01% 8909
2022
Q3 		$512K Buy
5,318
+3,813
+253% +$533K ﹤0.01% 8423
2022
Q2 		$253K Sell
1,505
-1,928
-56% -$293K ﹤0.01% 10021
2022
Q1 		$637K Sell
3,433
-9,353
-73% -$1.94M ﹤0.01% 8298
2021
Q4 		$3.42M Sell
12,786
-1,347
-10% -$353K ﹤0.01% 4419
2021
Q3 		$4.13M Buy
14,133
+7,719
+120% +$2.25M ﹤0.01% 4288
2021
Q2 		$1.59M Sell
6,414
-651
-9% -$167K ﹤0.01% 6492
2021
Q1 		$2.02M Buy
7,065
+6,633
+1,535% +$2.65M ﹤0.01% 5889
2020
Q4 		$121K Sell
432
-8,960
-95% -$3.32M ﹤0.01% 10388
2020
Q3 		$3.83M Buy
9,392
+4,547
+94% +$2.34M ﹤0.01% 3454
2020
Q2 		$2.81M Buy
4,845
+3,136
+183% +$1.43M ﹤0.01% 3900
2020
Q1 		$391K Buy
+1,709
New +$296K ﹤0.01% 7457

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's CODX Position: Q2 2026 in Review

Jeff Yass opened a new position in Co-Diagnostics (CODX) in Q2 2026: 31,239 shares worth $96.8K. The stake represents ﹤0.01% of the portfolio and ranks #12518 among its holdings. This is a return to the name: Jeff Yass previously reported a position in CODX as recently as Q4 2025.

Jeff Yass first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.13M in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Jeff Yass held 31,239 shares of Co-Diagnostics worth $96.8K as of Q2 2026.
  • Co-Diagnostics was a new Jeff Yass position in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12518 holding.
  • Jeff Yass first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Jeff Yass's Co-Diagnostics position peaked at $4.13M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.